Download PDF
Thromb Haemost 1998; 79(02): 282-285
DOI: 10.1055/s-0037-1614978
Letters to the Editor
Schattauer GmbH

IgA Anticardiolipin Antibodies – Relation with other Antiphospholipid Antibodies and Clinical Significance

Albert Selva-O’Callaghan
1   From the Department of Internal Medicine, Hospital General Vall D’Hebron, Spain
,
Josep Ordi-Ros
1   From the Department of Internal Medicine, Hospital General Vall D’Hebron, Spain
,
Francesc Monegal-Ferran
1   From the Department of Internal Medicine, Hospital General Vall D’Hebron, Spain
,
Nuria Martinez
1   From the Department of Internal Medicine, Hospital General Vall D’Hebron, Spain
,
Fina Cortes-Hernandez
1   From the Department of Internal Medicine, Hospital General Vall D’Hebron, Spain
,
Miquel Vilardell-Tarres
1   From the Department of Internal Medicine, Hospital General Vall D’Hebron, Spain
› Author Affiliations
Further Information

Publication History

Received 15 May 1997

Accepted after resubmission 16 September 1997

Publication Date:
08 December 2017 (online)

    Permissions and Reprints

Summary

Objective: To evaluate the usefulness of IgA antiphospholipid antibodies as markers of thrombosis and/or antiphospholipid antibody syndrome. Patients and Methods: A cross-sectional study design in a tertiary, university-based, autoimmune reference hospital. Seven-hundred ninety-five patients classified into five different groups – autoimmune diseases (255), deep vein thrombosis (153), transitory ischemic attacks (108), obstetric complications (196), infectious diseases (83) and controls (81) – were tested for IgA, IgG and IgM aPL, and lupus anticoagulant. Plasma and serum samples were drawn for detection of aPL using an internationally standardized ELISA method and LA was carried out using coagulometric assays. Results: True IgA aPL were found only in two patients with systemic lupus erythematosus; these patients were also positive to IgG aPL. Conclusion: The incidence of true positivity to IgA anticardiolipin antibodies is extremely low. Their determination was not helpful in diagnosing the antiphospholipid syndrome or in explaining thrombotic events or aPL related manifestations – fetal loss – in the groups studied.

 

  • References

  • 1 Harris EN, Gharavi AE, Boey ML, Patel BM, Mackworth-Young CG, Loizou S. et al. Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet 1983; ii: 1211-4.
    PubMedGoogle Scholar
  • 2 McNeil HP, Chesterman CN, Krillis SA. Immunology and clinical importance of antiphospholid antibodies. Adv Immunol 1991; 49: 193-280.
    PubMedGoogle Scholar
  • 3 Galli M, Beretta G, Daldossi M, Bevers E, Barbui T. Different anticoagulant and immunological properties of anti-prothrombin antibodies in patients with antiphospholipid antibodies. Thromb Haemost 1997; 77: 496-1.
    PubMedGoogle Scholar
  • 4 Ordi J, Selva A, Monegal F, Porcel JM, Martínez-Costa X, Vilardell M. Anticardiolipin Antibodies and Dependence of a Serum Cofactor. A Mechanism of Thrombosis. J Rheumatol 1993; 20: 1321-4.
    PubMedGoogle Scholar
  • 5 Asherson RA, Khamashta MA, Ordi-Ros J, Derksen RHWM, Machin SJ, Path FRC. et al. The “Primary” Antiphospholipid Syndrome: Major Clinical and Serological Features. Medicine (Baltimore) 1989; 68: 366-74.
    CrossrefPubMedGoogle Scholar
  • 6 Love PE, Santoro SA. Antiphospholipid Antibodies: Anticardiolipin and the Lupus Anticoagulant in Systemic Lupus Erythematosus (SLE) and in Non-SLE Disorders. Ann Intern Med 1990; 112: 682-98.
    CrossrefPubMedGoogle Scholar
  • 7 Ordi J, Barquinero J, Vilardell M, Tolosa C, Jordana R, Selva A. et al. Fetal loss treatment in patients with antiphospholipid antibodies. Ann Rheum Dis 1989; 48: 798-802.
    CrossrefPubMedGoogle Scholar
  • 8 Galve E, Ordi J, Permanyer G, Vilardell M, Soler J. Valvular Heart Disease in Systemic Lupus Erythematosus. N Engl J Med 1989; 320: 740-1.
    PubMedGoogle Scholar
  • 9 Gharavi AE, Harris EN, Asherson RA, Hughes GRV. Anticardiolipin antibodies: isotype distribution and phospholipid specificity. Ann Rheum Dis 1987; 46: 1-6.
    CrossrefPubMedGoogle Scholar
  • 10 Loizou S, Cofiner C, Weetman AP, Walport MJ. Immunoglobulin class and IgG subclass distribution of anticardiolipin antibodies in patients with systemic lupus erythematosus and associated disorders. Clin Exp Immunol 1992; 90: 434-9.
    PubMedGoogle Scholar
  • 11 Lopez LR, Santos ME, Espinoza LR, LaRosa FG. Clinical significance of immunoglobulin A versus immunoglobulin G and M, anticardiolipin antibodies in patients with systemic lupus erythematosus. Correlation with thrombosis, thrombocytopenia, and recurrent abortion. Am J Clin Pathol 1992; 98: 449-54.
    CrossrefPubMedGoogle Scholar
  • 12 Tan EM, Cohen AS, Fries JF. et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1275.
    PubMedGoogle Scholar
  • 13 Loizou S, McRea JD, Rudge AG. et al. Measurement of anticardiolipin antibodies by an enzyme-linked immunosorbent assay (ELISA): standardization and quantitation of results. Clin Exp Immunol 1985; 62: 738-45.
    PubMedGoogle Scholar
  • 14 Harris EN, Gharavi AE, Patel SP, Hughes GRV. Evaluation of the anticardiolipin antibody test: report of an international workshop held 4 April 1986. Clin Exp Immunol 1987; 68: 215-22.
    PubMedGoogle Scholar
  • 15 Harris EN. The second international anti-cardiolipin standardization work-shop/the Kinston anti-phospholipid antibody study (KAPS) group. Am J Clin Pathol 1990; 94: 476-84.
    CrossrefPubMedGoogle Scholar
  • 16 Pierangelli SS, Davis SA, Harris EN. Calibration of an ELISA assay for the detection of IgA anticardiolipin antibodies. Clin Exp Rheumatol 1992; 10: 641.
    PubMedGoogle Scholar
  • 17 Cowchock S, Fort J, Muñoz S, Norberg R, Maddrey W. False positive ELISA tests for anticardiolipin antibodies in sera from patients with repeated abortion, rheumatologic disorders and primary biliary cirrhosis: correlation with elevated polyclonal IgM and implications for patients with repeated abortion. Clin Exp Immunol 1988; 73: 289-94.
    PubMedGoogle Scholar
  • 18 Exner T, Rickard KA, Kronenberg H. A sensitive test demostrating lupus anticoagulant and its behavioural patterns. Br J Haematol 1978; 40: 143-51.
    CrossrefPubMedGoogle Scholar
  • 19 Thiagarajan P, Pengo V, Shapiro SS. The use of the diluted Russell viper-venom time for the diagnosis of lupus anticoagulants. Blood 1986; 68: 869-74.
    PubMedGoogle Scholar
  • 20 Schleider MA, Nachman RL, Jaffe EA, Coleman M. A clinical study of the lupus anticoagulant. Blood 1976; 48: 499-509.
    PubMedGoogle Scholar
  • 21 Brandt JT, Triplett DA, Alving B, Scharrer I. Criteria for the diagnosis of lupus anticoagulant: An Update. Thromb Haemost 1995; 74: 1185-90.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 22 Ordi-Ros J, Selva-O’Callaghan A, Monegal-Ferran F, Monasterio-Aspiri Y, Vilardell-Tarrés M. Prevalence, Significance and Specificity of Anti-phospholipid antibodies in Q fever. Clin Infect Dis 1994; 18: 213-7.
    CrossrefPubMedGoogle Scholar
  • 23 Frampton G, Winer JB, Cameron JS. et al. Severe Guillain-Barré syndrome: an association with IgA anti-cardiolipin antibody in a series of of 92 patients. J Neuroimmunol 1988; 19: 133-9.
    CrossrefPubMedGoogle Scholar
  • 24 Collier D, Enzenauer R, Santos M. et al. IgA anticardiolipin antibody associated with interstitial lung disease in systemic sclerosis. Arthritis Rheum 1992; 35 (Suppl. 09) S346.
    PubMedGoogle Scholar
  • 25 Fonollosa V, Selva A, Simeon CP, Lima J, Vilardell M. Anticardiolipin antibodies in systemic sclerosis. J Am Acad Dermatol 1991; 25: 133-4.
    PubMedGoogle Scholar
  • 26 Burden AD, Tillman DM, Foley P, Holme E. IgA class anticardiolipin antibodies in cutaneous leukocytoclastic vasculitis. J Am Acad Dermatol 1996; 35: 411-5.
    CrossrefPubMedGoogle Scholar
  • 27 Escalante A, Brey RL, Mitchel BD, Dreiner E. Accuracy of Anticardiolipin Antibodies in Identifying a History of Thrombosis among Patients with Systemic Lupus Erythematosus. Am J Med 1995; 98: 559-65.
    CrossrefPubMedGoogle Scholar
  • 28 Hamachi-Lopez M, Carlton E, Sferruza A. Incidence of Anti-Cardiolipin IgA Antibodies Versus IgG/IgM in a high Volume Reference Lab. Lupus 1996; 5: 555 (Abstract).
    PubMedGoogle Scholar
  • 29 Merkel PA, Chang YC, Pierangeli S, Convery K, Harris EN, Polisson RP. The Prevalence and Clinical Associations of Anticardiolipin Antibodies in a Large Inception Cohort of Patients with Connective Tissue Diseases. Am J Med 1996; 101: 576-83.
    CrossrefPubMedGoogle Scholar